Whitehawk Therapeutics, Inc. SEC filings WHWK
Whitehawk Therapeutics, Inc. has 671 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | May 29, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 424B5 | Prospectus supplement | Apr 25, 2025 | — |
| S-3 | Shelf registration | Mar 31, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 424B5 | Prospectus supplement | May 3, 2024 | — |
| S-8 | Employee stock plan registration | Feb 12, 2024 | — |
| S-3 | Shelf registration | Feb 12, 2024 | — |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| 424B3 | Prospectus | Nov 4, 2022 | — |
| S-3 | Shelf registration | Oct 26, 2022 | — |
| 424B5 | Prospectus supplement | Mar 21, 2022 | — |
| 424B5 | Prospectus supplement | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 424B3 | Prospectus | Oct 4, 2021 | — |
| S-8 | Employee stock plan registration | Sep 24, 2021 | — |
| S-3 | Shelf registration | Sep 24, 2021 | — |
| S-3 | Shelf registration | Apr 8, 2021 | — |
| 424B5 | Prospectus supplement | Sep 25, 2020 | — |
| 424B5 | Prospectus supplement | Aug 5, 2020 | — |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| S-8 | Employee stock plan registration | Mar 7, 2019 | — |
| S-8 | Employee stock plan registration | Dec 28, 2018 | — |
| S-3 | Shelf registration | Dec 28, 2018 | — |
| POS AM | Filing | Aug 31, 2018 | — |
| 424B5 | Prospectus supplement | Jun 26, 2018 | — |
| 424B5 | Prospectus supplement | Jun 25, 2018 | — |
| 424B3 | Prospectus | Jun 25, 2018 | — |
| 424B3 | Prospectus | Jun 22, 2018 | — |
| 424B3 | Prospectus | Jun 11, 2018 | — |
| 424B3 | Prospectus | May 25, 2018 | — |
| 424B3 | Prospectus | May 25, 2018 | — |
| 424B3 | Prospectus | May 25, 2018 | — |
| S-8 | Employee stock plan registration | Apr 6, 2018 | — |
| S-3/A | Filing | Apr 6, 2018 | — |
| S-3 | Shelf registration | Feb 21, 2018 | — |
| 424B3 | Prospectus | Dec 18, 2017 | — |
| 424B3 | Prospectus | Nov 14, 2017 | — |
| 424B3 | Prospectus | Nov 13, 2017 | — |
| 424B3 | Prospectus | Oct 10, 2017 | — |
| S-8 | Employee stock plan registration | Aug 18, 2017 | — |
| 424B3 | Prospectus | Aug 15, 2017 | — |
| 424B3 | Prospectus | Aug 8, 2017 | — |
| 424B3 | Prospectus | Jul 31, 2017 | — |
| 424B3 | Prospectus | Jun 29, 2017 | — |
| 424B3 | Prospectus | Jun 26, 2017 | — |
| S-1/A | Amended registration statement | Jun 9, 2017 | — |
| S-1/A | Amended registration statement | May 22, 2017 | — |
| S-1 | Registration statement | Apr 14, 2017 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- WHWK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Morristown, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1422142
- Former names
- Aadi Bioscience, Inc. (until Mar 18, 2025); Aerpio Pharmaceuticals, Inc. (until Aug 23, 2021); ZETA ACQUISITION CORP II (until Mar 13, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.